| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.653 | 25.157 | 22.007 | 24.124 | 23.339 | 20.625 | 25.648 | 28.406 | 32.235 | 35.242 |
| Total Income - EUR | 13.653 | 53.205 | 22.118 | 24.127 | 33.031 | 28.597 | 25.652 | 28.411 | 32.235 | 35.242 |
| Total Expenses - EUR | 19.326 | 27.650 | 27.284 | 29.704 | 31.252 | 27.475 | 30.612 | 29.680 | 32.478 | 33.901 |
| Gross Profit/Loss - EUR | -5.673 | 25.555 | -5.166 | -5.577 | 1.779 | 1.122 | -4.959 | -1.269 | -243 | 1.341 |
| Net Profit/Loss - EUR | -6.083 | 25.023 | -5.388 | -5.818 | 1.449 | 843 | -5.209 | -1.553 | -565 | 1.062 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Polivalexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.535 | 1.531 | 1.348 |
| Current Assets | 2.460 | 3.064 | 2.719 | 2.790 | 2.187 | 1.465 | 1.831 | 1.831 | 1.225 | 1.823 |
| Inventories | 2.311 | 1.940 | 1.588 | 2.237 | 1.855 | 1.310 | 1.280 | 1.581 | 633 | 1.234 |
| Receivables | 13 | 108 | 9 | 101 | 0 | 0 | 306 | 83 | 0 | 228 |
| Cash | 136 | 1.015 | 1.122 | 452 | 332 | 155 | 245 | 167 | 592 | 362 |
| Shareholders Funds | -26.916 | -1.619 | -6.979 | -12.667 | -10.973 | -9.922 | -14.911 | -16.510 | -17.025 | -15.868 |
| Social Capital | 45 | 45 | 44 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 29.376 | 4.683 | 9.698 | 15.457 | 13.160 | 11.387 | 16.742 | 19.877 | 19.781 | 19.038 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Polivalexim Srl